Condition 1: Bone pains in Cancer patients with bone metastases. Condition 2: Hypercalcemia in Cancer patients with bone metastases. Condition 3: Quality of life in Cancer patients with bone metastases. Secondary malignant neoplasm of bone and bone marrow Disorders of calcium metabolism Lifestyle-related condition
Conditions
Interventions
In this study, Pamidronic Acid Ampule (90 mg) with Pamidronate brand name (Made in Hospira company) was intravenously injected for 3 months (one per month) along with 500 mL of Normal Saline during 2-
Treatment - Drugs
Sponsors
Vice chancellor for research of Tonekabon Islamic Azad University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: Malignancy with bone metastasis Exclusion criteria: Renal dysfunction history, Creatinine more than 2mg/dl, Treatment of Hypocalcemia with other Bisphosphonates
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Taking Sedatives. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Questionnaire including Clinical data.;Taking Opiums. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Questionnaire including Clinical data. | — |
Primary
| Measure | Time frame |
|---|---|
| Bone pains. Timepoint: Before intervention - 3 months after intervention. Method of measurement: Visual Analoge Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hossein Ali Mashayekhi
Vice chancellor for research of Tonekabon Islamic Azad University
Outcome results
None listed